Bebtelovimab: considerations for global access to treatments during a rapidly evolving pandemic.
Lancet Infect Dis
; 22(11): 1531, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-2058781
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Influenza, Human
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Lancet Infect Dis
Journal subject:
Communicable Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS